{"organizations": [], "uuid": "11c4371e7ae44c086485135430edfd38813f2a35", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180305.html", "section_title": "Archive News &amp; Video for Monday, 05 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/clearside-study/clearside-biomedicals-eye-treatment-succeeds-late-stage-study-idUSL4N1QN4GH", "country": "US", "domain_rank": 408, "title": "Clearside Biomedical's eye treatment succeeds late-stage study", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.002, "site_type": "news", "published": "2018-03-05T20:31:00.000+02:00", "replies_count": 0, "uuid": "11c4371e7ae44c086485135430edfd38813f2a35"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/clearside-study/clearside-biomedicals-eye-treatment-succeeds-late-stage-study-idUSL4N1QN4GH", "ord_in_thread": 0, "title": "Clearside Biomedical's eye treatment succeeds late-stage study", "locations": [], "entities": {"persons": [{"name": "manas mishra", "sentiment": "none"}, {"name": "arun koyyur", "sentiment": "none"}], "locations": [{"name": "bengaluru", "sentiment": "none"}, {"name": "alpharetta", "sentiment": "none"}], "organizations": [{"name": "clearside biomedical", "sentiment": "negative"}, {"name": "reuters) - clearside biomedical inc", "sentiment": "neutral"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 5 (Reuters) - Clearside Biomedical Inc said on Monday its treatment for fluid build-up in the eye had met the main goal of a late-stage study.\nShares of the Alpharetta, Georgia-based drug developer jumped 52.2 percent at $11.90 in premarket trading.\nThe drug was being tested in patients with macular edema associated with non-infectious uveitis.\nReporting by Manas Mishra in Bengaluru; Editing by Arun Koyyur\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-05T20:31:00.000+02:00", "crawled": "2018-03-06T22:24:36.002+02:00", "highlightTitle": ""}